|
1
|
Slattery ML and Fitzpatrick FA:
Convergence of hormones, inflammation, and energy-related factors:
A novel pathway of cancer etiology. Cancer Prev Res (Phila).
2:922–930. 2009. View Article : Google Scholar
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grady WM and Carethers JM: Genomic and
epigenetic instability in colorectal cancer pathogenesis.
Gastroenterology. 135:1079–1099. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vogelstein B and Kinzler KW: Cancer genes
and the pathways they control. Nat Med. 10:789–799. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hofmanová J, Straková N, Vaculová AH,
Tylichová Z, Safaříková B, Skender B and Kozubík A: Interaction of
dietary fatty acids with tumour necrosis factor family cytokines
during colon inflammation and cancer. Mediators Inflamm.
2014:8486322014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen D, Yu Z, Zhu Z and Lopez CD: The p53
pathway promotes efficient mitochondrial DNA base excision repair
in colorectal cancer cells. Cancer Res. 66:3485–3494. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nichols J, Zevnik B, Anastassiadis K, Niwa
H, Klewe-Nebenius D, Chambers I, Schöler H and Smith A: Formation
of pluripotent stem cells in the mammalian embryo depends on the
POU transcription factor Oct4. Cell. 95:379–391. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fankam AG, Kuiate JR and Kuete V:
Antibacterial activities of Beilschmiedia obscura and six other
Cameroonian medicinal plants against multi-drug resistant
Gram-negative phenotypes. BMC Complement Altern Med. 14:2412014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sui H, Liu X, Jin BH, Pan SF, Zhou LH, Yu
NA, Wu J, Cai JF, Fan ZZ, Zhu HR, et al: Zuo Jin Wan, a traditional
Chinese herbal formula, reverses P-gp-mediated MDR in vitro and in
vivo. Evid Based Complement Alternat Med. 2013:9570782013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sui H, Fan ZZ and Li Q: Signal
transduction pathways and transcriptional mechanisms of
ABCB1/Pgp-mediated multiple drug resistance in human cancer cells.
J Int Med Res. 40:426–435. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ
and Andrews PW: OCT4 spliced variants are differentially expressed
in human pluripotent and nonpluripotent cells. Stem Cells.
26:3068–3074. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X and Dai J: Concise review: Isoforms
of OCT4 contribute to the confusing diversity in stem cell biology.
Stem Cells. 28:885–893. 2010.PubMed/NCBI
|
|
13
|
Li R, Liang J, Ni S, Zhou T, Qing X, Li H,
He W, Chen J, Li F, Zhuang Q, et al: A mesenchymal-to-epithelial
transition initiates and is required for the nuclear reprogramming
of mouse fibroblasts. Cell Stem Cell. 7:51–63. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Z, Li X, Li C, Su Y, Fang W, Zhong C,
Ji W, Zhang Q and Su C: Transcription factor OCT4 promotes cell
cycle progression by regulating CCND1 expression in esophageal
carcinoma. Cancer Lett. 354:77–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Asadzadeh J, Asadi MH, Shakhssalim N,
Rafiee MR, Kalhor HR, Tavallaei M and Mowla SJ: A plausible
anti-apoptotic role of up-regulated OCT4B1 in bladder tumors. Urol
J. 9:574–580. 2012.PubMed/NCBI
|
|
16
|
Asadi MH, Mowla SJ, Fathi F, Aleyasin A,
Asadzadeh J and Atlasi Y: OCT4B1, a novel spliced variant of OCT4,
is highly expressed in gastric cancer and acts as an antiapoptotic
factor. Int J Cancer. 128:2645–2652. 2011. View Article : Google Scholar
|
|
17
|
Mirzaei MR, Najafi A, Arababadi MK, Asadi
MH and Mowla SJ: Altered expression of apoptotic genes in response
to OCT4B1 suppression in human tumor cell lines. Tumour Biol.
35:9999–10009. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Valianou M, Cox AM, Pichette B, Hartley S,
Paladhi UR and Astrinidis A: Pharmacological inhibition of
polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and
survival of hamartin and tuberin deficient cells via induction of
apoptosis and attenuation of autophagy. Cell Cycle. 14:399–407.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen L, Zhang JJ and Huang XY: cAMP
inhibits cell migration by interfering with Rac-induced
lamellipodium formation. J Biol Chem. 283:13799–13805. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee J, Kim HK, Rho JY, Han YM and Kim J:
The human OCT-4 isoforms differ in their ability to confer
self-renewal. J Biol Chem. 281:33554–33565. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Zhao Y, Xiao Z, Chen B, Wei Z,
Wang B, Zhang J, Han J, Gao Y, Li L, et al: Alternative translation
of OCT4 by an internal ribosome entry site and its novel function
in stress response. Stem Cells. 27:1265–1275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pardal R, Clarke MF and Morrison SJ:
Applying the principles of stem-cell biology to cancer. Nat Rev
Cancer. 3:895–902. 2003. View
Article : Google Scholar
|
|
23
|
Al-Hajj M and Clarke MF: Self-renewal and
solid tumor stem cells. Oncogene. 23:7274–7282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lobo NA, Shimono Y, Qian D and Clarke MF:
The biology of cancer stem cells. Annu Rev Cell Dev Biol.
23:675–699. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Junker K, Wolf M and Schubert J: Molecular
clonal analysis of recurrent bladder cancer. Oncol Rep. 14:319–323.
2005.PubMed/NCBI
|
|
26
|
Engers R: Reproducibility and reliability
of tumor grading in urological neoplasms. World J Urol. 25:595–605.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang XK, To KK, Huang LY, Xu JH, Yang K,
Wang F, Huang ZC, Ye S and Fu LW: Afatinib circumvents multidrug
resistance via dually inhibiting ATP binding cassette subfamily G
member 2 in vitro and in vivo. Oncotarget. 5:11971–11985. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Greenberg RM: Schistosome ABC multidrug
transporters: From pharmacology to physiology. Int J Parasitol
Drugs Drug Resist. 4:301–309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Servant G, Weiner OD, Herzmark P, Balla T,
Sedat JW and Bourne HR: Polarization of chemoattractant receptor
signaling during neutrophil chemotaxis. Science. 287:1037–1040.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
